A tissue therapeutics revolution

CUTISS is the only late-stage clinical TechBio company developing skin tissue therapeutics and dedicated to bioengineering. We are transforming skin surgery with denovoSkin™, our first-in-class personalized tissue therapy that enables automated, on-demand production of living skin at scale.

The only living, true human skin – on demand

Developed for patients requiring skin surgery – from massive burns to reconstructive and aesthetic applications – denovoSkin™ has shown long-term safety and efficacy compared to the standard of care.

In-house manufacturing

We manufacture denovoSkin™ for clinical use at our state-of-the-art, certified Good Manufacturing Practice (GMP) facility in Zurich, Switzerland.

Play Video

Highly-scalable, automated production

We have developed a first-in-class automation platform for the scalable production of personalized tissue therapy. It is a patented, fully-closed, end-to-end system that enables decentralized production, cost-effective scale-up, and high return on investment.

This pioneering platform allows for expansion across multiple frontiers:

In regenerative medicine, enabling the development of next-priority tissues such as gums, cornea, and muscle, making personalized treatments more accessible at the point of care.
In Space Health research, accelerating discoveries in healing and ageing.
Beyond healthcare, driving the high-scale production of bioengineered tissues for industrial applications.